MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trials Search

Search Clinical Trials By:

-- Select One --

Showing 1 to 3 of 3
<<
1 - 3
>>
Clinical Trials
A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with ‘Systemic Sclerosis associated Interstitial Lung Disease’(SSc-ILD).
An Open-Label Extension Study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease
BIPI Protocols 1199.247: A Double-blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52-weeks in Patients with Progressive Fibrosing Interstital Lung Disease (PF-ILD)